Latest news with #RobertGoldsmith
Yahoo
25-04-2025
- Health
- Yahoo
PER® Presents More Than a Dozen Free CME/CE Symposia at the Annual Oncology Meeting in Chicago
Evening events offer high-impact, case-based learning with top experts—available in person or virtually CHICAGO, April 25, 2025 (GLOBE NEWSWIRE) -- This May, during one of the most important weeks in cancer care, Physicians' Education Resource®, LLC (PER®), the go-to educational resource for health care professionals across all specialties to advance patient care, will host more than a dozen free, accredited CME/CE symposia designed to elevate clinical practice and deliver deeper understanding of the latest advances in oncology. These highly anticipated programs will take place May 30 through June 3 at the Sheraton Grand Chicago Riverwalk and Hilton Chicago, with virtual options available for every session. Tailored for oncologists, nurses, nurse practitioners (NPs), physician assistants (PAs), pharmacists, and other health care professionals on the front lines of cancer care, PER's evening symposia go beyond the data dumps. The lectures are designed to be immersive learning experiences that pair dinner and discussion with some of the most respected voices in oncology. Each session digs into timely, complex topics using real-world cases, cutting-edge science, and the clinical nuance that transforms evidence into action. The programs cover the full spectrum of oncology, from HER2 and TROP2-targeted strategies in lung cancer and next-generation endocrine therapies in breast cancer to innovative treatments for small cell lung cancer, immune thrombocytopenic purpura, ovarian cancer, and glioma. The sessions feature PER's signature formats, including Medical Crossfire® debates, Tumor Board-style discussions, and Show Me the Data™ presentations designed to spark insights and sharpen clinical decision-making. 'We know oncology professionals are overwhelmed with data during this week, but they're also hungry for practical, peer-driven education they can actually use,' said Robert Goldsmith, senior vice president of oncology corporate development at MJH Life Sciences®. 'These symposia are where science meets strategy. They offer the kind of insight, access, and interaction that doesn't happen during the main conference sessions.' Each evening starts with registration and dinner at 6 p.m. CDT, followed by scientific sessions beginning at 6:30 p.m. CDT. All activities are CME/CE accredited and free to attend, with options to participate in person or virtually. Seats for in-person sessions are limited, and advance registration is strongly recommended for a chance to engage with peers, connect with experts, and come away with knowledge that can immediately impact patient care. The full schedule and registration details can be found at About Physicians' Education Resource Physicians' Education Resource (PER), is committed to advancing patient care through professional education. Accredited by the Accreditation Council for Continuing Medical Education (ACCME) and approved as a nursing continuing education provider by the California Board of Registered Nursing, PER is the educational resource of choice for live and online activities for health care professionals across a broad range of specialties. Based on identified needs and practice gaps, PER provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. About MJH Life Sciences MJH Life Sciences is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit Media Contact:Julia ParadizovaMJH Life Sciencesjparadizova@ in to access your portfolio
Yahoo
21-04-2025
- Health
- Yahoo
OncLive® Launches Scout, an AI Assistant to Help Oncologists Quickly Access Expert Insights
OncLive® Launches Scout, an AI Assistant to Help Oncologists Quickly Access Expert Insights CRANBURY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- OncLive®, the leading resource for oncology professionals, today formally announced the beta release of Scout, an artificial intelligence-powered assistant developed to streamline access to expert clinical insight and research-based commentary. Scout is accessible on both the desktop and mobile versions of First introduced in March as a beta tool, Scout is designed to support oncology clinicians by delivering concise, contextually relevant answers derived from a trusted set of oncology news, research, and multimedia programming. The AI model is trained on an extensive library of expert-driven video discussions from OncLive's signature programs, including Peer Exchange and Insights, to deliver results that are accurate, timely, and rooted in expert opinion. Scout offers a practical and time-saving utility by synthesizing complex clinical discussions into succinct responses grounded in expert consensus. Each result includes direct reference links and navigational tools that allow users to view the exact segment within a video where a cited opinion or insight was delivered, eliminating the need for manual searching. 'Scout was created with the goal of enhancing clinical efficiency by enabling physicians to access high-quality, peer-informed content in real time,' said Robert Goldsmith, senior vice president of oncology corporate development at MJH Life Sciences®. 'By leveraging OncLive's deep content repository and integrating it with advanced AI capabilities, Scout represents an evolution in how oncology professionals interact with medical information by delivering relevant, expert-based guidance within seconds.' Designed to fit seamlessly into an oncologist's workflow, Scout provides: Succinct summaries based on expert video commentary and published articles. Quick-reference links to related reading and supporting resources. Direct video navigation to the exact moment an expert delivers their commentary. Mobile-responsive functionality, optimized for use on the go. Scout remains in beta as ongoing development and refinement continue in partnership with the oncology community. The platform is actively gathering user feedback to inform enhancements and future iterations. A mobile application is currently in development and is anticipated to be released later this year. Scout is available now on via desktop and mobile browsers. For more information or to try Scout, visit and click the Scout icon in the navigation bar. About OncLive The leading digital platform and multichannel resource for practicing oncologists, OncLive offers oncology professionals peer-to-peer insights, news and practical information they can use to offer the best patient care. OncLive is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels. About MJH Life Sciences MJH Life Sciences is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit Media Contact:Julia ParadizovaMJH Life Sciencesjparadizova@ A photo accompanying this announcement is available at in to access your portfolio
